“…This protein was demonstrated to be as potent as the reference carrier tetanus toxoid already used in human conjugate vaccines since it was able to induce strong antibody responses against B cell epitopes, such as peptides [16,17] and bacterial polysaccharides [17][18][19] coupled to it. Moreover, the protein also works as a potent immunological adjuvant for specific cytotoxic T lymphocyte (CTL) response induction in vivo [20,21].…”